IRF3 and cancer: Knockdown experiments showed that IFN-β secretion was inhibited by RIG-I and MAVS knockdown, demonstrating that most of cancer cells responded to cytosolic RNA through the RIG-I–MAVS–IRF3 signaling pathway.